Christopher A. Lipinski PhD

Dr. Lipinski is a medicinal chemist with more than 34 years of experience at Pfizer, Inc. In 2002 he retired from the highest scientific position in the worldwide Pfizer research organization (Senior Research Fellow) and now serves as a Drug-Like Properties consultant to Pfizer. Dr. Lipinski is renowned for his "Rule of Five"; an algorithm for predicting drug compounds likely to show oral activity (See Appendix B). His 1997 publication in "Advanced Drug Delivery Reviews", where the "Rule of Five" first appears, is the most frequently cited medicinal chemistry paper in the last decade and is one of the most cited publications in the journal's history. He was the recipient of the American Chemical Societies 2004 Medicinal Chemistry award.

Dr. Lipinski received a B.Sc. degree in chemistry from San Francisco State College in 1965 and a Ph.D. in 1968 in physical organic chemistry from the University of California, Berkeley. He joined Pfizer in 1970 following a National Institutes of General Medical Sciences Postdoctoral Fellowship at the California Institute of Technology.